Compound 15c, a Novel Dual Inhibitor of EGFRL858R/T790M and FGFR1, Efficiently Overcomes Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance of Non-Small-Cell Lung Cancers

Gaozhi Chen(Wenzhou Medical University), Guang Liang(Wenzhou Medical University)
Frontiers in Pharmacology
January 9, 2020
Cited by 16


Related Papers